Vicure Tablets 0.5mg | Antivirals | Pharmaceuticals | Products

Vicure Tablets 0.5mg

Code:

DRPS0195A

Active Ingredient:

Entecavir 0.5mg

Description:

White, triangular-shaped, film-coated tablet with "IDP" on one side

Regulatory Class:

P1S1S3
Prescription Drug

HK-65996

Indication
Indication
Use and Administration

Indication

Use and Administration

Entecavir is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with:
• compensated liver disease and evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis.
• decompensated liver disease.
For both compensated and decompensated liver disease, this indication is based on clinical trial data in nucleoside naive patients with HBeAg positive and HBeAg negative HBV infection.

Therapy should be initiated by a physician experienced in the management of chronic hepatitis B infection.
Posology
Entecavir should be taken orally.
Compensated liver disease
Nucleoside naïve patients: the recommended dose in adults is 0.5 mg once daily, with or without food.